< previous page | page_226 | next page >
Page 226
| condition. This is part of the theory behind proteolytic enzyme therapy in cancer. Through this mechanism, proteolytic enzymes can also down-regulate an overactive immune system, thereby making them useful in treating autoimmune diseases as well. |
| A great deal of research on proteolytic enzymes is currently going on in many laboratories and cancer research centers around the world. One study of the use of enzymes combined with radiation therapy showed that those taking enzymes had a greater sense of general well-being, were better able to tolerate radiation, and required fewer drugs to offset the side effects of radiation treatments. 125 |
| An important part of my protocols for inhibiting cancer involves the combination of either Wobenzym supplementation or bromelain, a proteolytic enzyme derived from pineapple, with turmeric extract tablets containing 95 percent curcumin, quercetin, and sometimes one or more medical mushroom extract capsules (reishi, maitake, shiitake). Besides turmeric's anticancer, anti-oxidant, anti-inflammatory, fibrinolytic, and liver-protective properties, I believe it has a synergistic effect with enzyme therapy, particularly bromelain. |
| Cancer cells produce excessive amounts of fibrin, and therefore people who have cancer are more likely to develop blood dots, emboli, phlebitis, and thromboses. Fibrin is used by the cancer cells as a form of camouflage called glycoprotein shield. This protects the cancer cells from the immune system. Proteolytic enzymes, along with turmeric (which acts as an anticoagulant and fibrolytic agent), unmask the fibrin coating of cancer cells, thereby allowing attack from the immune system. This removes the stickiness of the cancer cell and helps to reduce the spread of cancer. |
| Proteolytic enzymes may also benefit patients undergoing radiation/chemotherapy by reducing side effects and exposing cancer cells to the cytotoxic agents, allowing for better effectiveness. |
| L-asparaginase, another enzyme preparation produced from yeast, is a valuable therapeutic modality for the treatment of both acute lymphoblastic leukemia and acute nonlymphoblastic leukemia.126 |
| Bromelain |
| Bromelain causes interference with the growth of malignant cells by inhibiting the production of a mucus substance that protects the surface of the can- |
< previous page | page_226 | next page >

If you like this book, buy it!